Picture of Pharmena SA logo

PHR Pharmena SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+1.87%
3m+17.12%
6m-5.61%
1yr+7.71%
Volume Change (%)
10d/3m+81.34%
Price vs... (%)
52w High-18.72%
50d MA+5.29%
200d MA+9.81%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital146.48%
Return on Equity315.69%
Operating Margin530.77%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Pharmena SA EPS forecast chart

Profile Summary

Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
April 17th, 2008
Public Since
August 25th, 2008
No. of Employees
24
Sector
Personal & Household Products & Services
Industry
Consumer Defensives
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
11,137,758

PHR Share Price Performance

Upcoming Events for PHR

Full Year 2023 Pharmena SA Earnings Release

Q1 2024 Pharmena SA Earnings Release

Pharmena SA Annual Shareholders Meeting

Similar to PHR

Picture of 4Mass SA logo

4Mass SA

pl flag iconWarsaw Stock Exchange

Picture of Auxilia SA logo

Auxilia SA

pl flag iconWarsaw Stock Exchange

Picture of Delko SA logo

Delko SA

pl flag iconWarsaw Stock Exchange

Picture of Euro-Tax pl SA logo

Euro-Tax pl SA

pl flag iconWarsaw Stock Exchange

Picture of Global Cosmed SA logo

Global Cosmed SA

pl flag iconWarsaw Stock Exchange

FAQ